Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension
Open Access
- 1 May 2000
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 31 (5) , 1061-1067
- https://doi.org/10.1053/he.2000.6779
Abstract
Noninvasive measurements of variceal pressure adequately reflect the hemodynamic effects of propranolol on portal hypertension. However, the prognostic value of variceal pressure responses during continued propranolol therapy has not been evaluated, and it is unclear whether this may substitute invasive measurements of portal pressure response. Fifty-five portal hypertensive patients with cirrhosis were studied before and at 4 months of continued propranolol therapy. Variceal pressure was measured using an endoscopic pressure gauge. Portal pressure was evaluated as the hepatic venous pressure gradient (HVPG). Over a 28 ± 11 month follow-up, 16 patients experienced variceal bleeding. Baseline characteristics were similar in bleeders and nonbleeders. At 4 months, reduction in variceal pressure was less marked in bleeders than in nonbleeders (5% ± 20% vs. −15% ± 24%; P = .03). A fall in variceal pressure 20% or greater of baseline was an independent predictor of absence of variceal bleeding; which occurred in 5% of patients with a 20% or greater fall in variceal pressure versus 42% of patients with less than a 20% reduction (P = .004). The HVPG response had similar independent prognostic value (decrease ≥20%: 6% bleeding; decrease P = .004) but identified different patients. Achieving a 20% decrease in either variceal pressure or HVPG was highly sensitive (85%) and specific (93%) identifying patients not bleeding on follow-up. Endoscopic measurements of variceal pressure response to continued pharmacotherapy provide useful prognostic information on the risk of variceal bleeding. As with HVPG response, a fall in variceal pressure of 20% or greater is associated with a very low risk of variceal bleeding. The combination of both parameters allows almost optimal prognostication.Keywords
This publication has 28 references indexed in Scilit:
- Nadolol plus Isosorbide Mononitrate Compared with Sclerotherapy for the Prevention of Variceal RebleedingNew England Journal of Medicine, 1996
- Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosisJournal of Hepatology, 1996
- Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosisPublished by Elsevier ,1995
- The treatment of portal hypertension: A meta-analytic reviewHepatology, 1995
- Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertensionHepatology, 1991
- Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhageGastroenterology, 1990
- Endoscopic Measurement of Variceal Pressure in Cirrhosis: Correlation With Portal Pressure and Variceal HemorrhageGastroenterology, 1989
- Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: Comparison with the effects on portal pressureHepatology, 1988
- Hemodynamic Factors Involved in the Development and Rupture of Esophageal Varices: A Pathophysiologic Approach to TreatmentSeminars in Liver Disease, 1986
- Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: Comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapyHepatology, 1986